MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports.

MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.

Hidden Harbor, Apax Partners and Heartwood Partners are amongst firms making investments in the fire safety sector.

Japanese chip distributor Macnica Holdings Inc. plans to expand its presence in fast-growing regions, including China and Southeast Asia. This is reported in a Macnica press release. Through the ...